| |
| |
|
| Insider
Information: |
Prelack Steven |
| Relationship: |
Director |
| City: |
Newton |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
131,674 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$409,919 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
131,674 |
|
|
| Total
Value |
$409,919 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Galectin Therapeutics Inc |
GALT |
Director |
2015-04-08 |
107,189 |
2013-03-12 |
0 |
Premium* |
|
|
Aadi Bioscience, Inc |
AADI |
Director |
2021-06-30 |
24,485 |
2021-03-31 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AADI |
Aadi Bioscience, Inc |
Director |
– • – |
2021-06-30 |
4 |
A |
$1.52 |
$18,748 |
D/D |
12,334 |
24,485 |
0 |
- |
|
| AADI |
Aadi Bioscience, Inc |
Director |
– • – |
2021-03-31 |
4 |
A |
$1.54 |
$18,749 |
D/D |
12,151 |
12,151 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2015-04-08 |
4 |
A |
$0.00 |
$0 |
D/D |
93,141 |
107,189 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2015-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
11,112 |
14,048 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2014-11-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(84,283) |
2,936 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2014-04-11 |
4 |
S |
$11.84 |
$71,040 |
D/D |
(6,000) |
87,219 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2014-01-31 |
4 |
D |
$13.71 |
$242,969 |
D/D |
(17,722) |
93,219 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2014-01-31 |
4 |
OE |
$0.72 |
$242,995 |
D/D |
108,005 |
110,941 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2013-03-12 |
4 |
D |
$4.22 |
$2,663 |
D/D |
(631) |
2,936 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2013-03-12 |
4 |
OE |
$2.28 |
$2,661 |
D/D |
1,167 |
3,567 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2012-06-15 |
5 |
A |
$2.14 |
$5,136 |
D/D |
2,400 |
2,400 |
0 |
- |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
